Finance

Lists
Q2 2027 earnings • released • EPS miss -42.35% • Revenue beat +11.23%
See results
JUBLPHARMA:NSE
Jubilant Pharmova Ltd
₹934.95
-2.05%
(-19.55) 1D
Nov 18, 3:12:52 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for JUBLPHARMA...
Open
₹949.95
High
₹953.90
Low
₹931.50
Mkt. cap
148.39B
Avg. vol.
189.31K
Volume
123.47K
Dividend
0.53%
Quarterly dividend
₹1.25
Ex-dividend date
Jul 24, 2026
P/E ratio
56.45
52-wk high
₹1,160.80
52-wk low
₹786.05
EPS
₹16.56
No. of employees
6K
Open
₹949.95
High
₹953.90
Low
₹931.50
Mkt. cap
148.39B
Avg. vol.
189.31K
Volume
123.47K
Dividend
0.53%
Quarterly dividend
₹1.25
Ex-dividend date
Jul 24, 2026
P/E ratio
56.45
52-wk high
₹1,160.80
52-wk low
₹786.05
EPS
₹16.56
No. of employees
6K
News stories
From web sources and news partners
About Jubilant Pharmova Ltd
CEO-
Employees5.66K
Founded1978
HeadquartersNoida, Uttar Pradesh, India
SectorHealth Care
IndustryPharmaceutical industry
Last report
Nov 16, 2026
Fiscal period
Q2 2027
₹1.96 / ₹3.40
-42.35%miss
Revenue / Est. (INR)
23.84B / 21.44B
+11.23%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
21.22B
22.90B
22.29B
23.84B
Cost of goods sold
7.16B
9.53B
7.49B
7.60B
Cost of revenue
7.16B
9.53B
7.49B
7.60B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.06B
8.34B
7.54B
8.30B
Operating expense
12.37B
11.14B
13.60B
15.04B
Total operating expenses
19.54B
20.68B
21.09B
22.64B
Operating income
1.69B
2.22B
1.21B
1.20B
Other non operating income
205.00M
-369.00M
199.00M
-
EBT including unusual items
934.00M
1.76B
864.00M
617.00M
EBT excluding unusual items
1.33B
1.87B
864.00M
617.00M
Income tax expense
376.00M
567.00M
300.00M
307.00M
Effective tax rate
40.26%
32.22%
34.72%
49.76%
Other operating expenses
4.10B
1.63B
4.79B
5.40B
Net income
559.00M
1.19B
565.00M
312.00M
Net profit margin
2.63%
5.21%
2.53%
1.31%
Earnings per share
5.01
8.10
3.56
1.96
Interest and investment income
-
252.00M
-
-
Interest expense
-561.00M
-461.00M
-542.00M
-584.00M
Net interest expenses
-561.00M
-209.00M
-542.00M
-584.00M
Depreciation and amortization charges
1.21B
1.17B
1.27B
1.35B
EBITDA
2.30B
2.98B
1.96B
2.51B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps